Pacira Pharmaceuticals, Inc. - NASDAQ: PCRX
About
Controlling postsurgical pain is the key to improving patient outcomes, yet up to 80% of patients report pain that is moderate to extreme in intensity after surgery.
Our in-depth knowledge of the needs of the postsurgical pain market, coupled with our passion for delivering improved patient care, drives our commitment to providing solutions that address unmet medical needs and improve clinical results. .